Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04130958 · ClinicalTrials.gov registry record · NA
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
A NA study of Suicide and Borderline Personality Disorder, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04130958 is a NA study of Suicide and Borderline Personality Disorder that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04130958, a NA study of Suicide and Borderline Personality Disorder, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This neuroimaging study is a clinical trial investigating the effectiveness of intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) in reducing suicide risk in patients with major depressive episode (MDE) or borderline personality disorder (BPD).
Conditions Studied
Interventions
- DEVICE Intermittent Theta Burst Transcranial Magnetic Stimulation (Active)
- DEVICE Intermittent Theta Burst Transcranial Magnetic Stimulation (Sham)
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04130958
The ClinicalTrials.gov registry entry for NCT04130958 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,989-participant average among 92 other Suicide trials with a reported enrollment target (99% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Intermittent Theta Burst Transcranial Magnetic Stimulation (Active) is the first listed.
NCT04130958 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04130958 about?
NCT04130958 is a clinical study titled "Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics". This neuroimaging study is a clinical trial investigating the effectiveness of intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) in reducing suicide risk in patients with major depressive episode (MDE) or borderline personality disorder (BPD)...
What is the current status of trial NCT04130958?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2023-11-01. Estimated completion is 2026-04-30.
What conditions does trial NCT04130958 study?
This clinical trial studies the following conditions: Suicide, Borderline Personality Disorder, Major Depressive Episode.
What interventions are being tested in trial NCT04130958?
The interventions under investigation include: Intermittent Theta Burst Transcranial Magnetic Stimulation (Active) (DEVICE), Intermittent Theta Burst Transcranial Magnetic Stimulation (Sham) (DEVICE).
Who is sponsoring clinical trial NCT04130958?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04130958 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.